Publications by authors named "M van den Hoven"
The impact of digital health technologies on moral responsibility: a scoping review.
Med Health Care Philos
November 2024
Article Synopsis
- Recent research on digital health technologies emphasizes the need for 'responsible' usage but often lacks clear definitions of what responsibility entails, leading to potential misunderstandings in healthcare delivery.
- The study examined 34 articles to understand how responsibility is interpreted in digital health realms, discovering that these technologies can alter roles among caregivers, patients, and devices and that moral responsibility is frequently misunderstood as merely accountability.
- The findings suggest a 'responsibility gap' in AI outcomes where no single party is held accountable, and raise questions about the appropriateness of increasing patient accountability through m-Health technologies, while calling for further exploration of collective responsibility and virtues in digital health.
Bovine respiratory syncytial virus (BRSV) causes infections of the respiratory tract of cattle and is endemic in the Netherlands. We aimed to update our knowledge on the seroprevalence of BRSV in youngstock on Dutch dairy farms by performing a cross sectional study during the winter of 2021-2022 and a telephone survey with the farmers to map the most important risk factors for the introduction, presence, and circulation of BRSV. Of 671 sampled calves among 135 herds, we found a seropositivity of 75 % at calf level and 77 % on herd level.
View Article and Find Full Text PDFA decoupling between confidence and action could relate to compulsive behaviour as seen in obsessive-compulsive disorder (OCD). The link between confidence and action in OCD has been investigated in clinical case-control studies and in the general population with discrepant findings. The generalizability of findings from highly-compulsive general population samples to clinical OCD samples has been questioned.
View Article and Find Full Text PDFQuantitative mobility analysis using wearable sensors, while promising as a diagnostic tool for Parkinson's disease (PD), is not commonly applied in clinical settings. Major obstacles include uncertainty regarding the best protocol for instrumented mobility testing and subsequent data processing, as well as the added workload and complexity of this multi-step process. To simplify sensor-based mobility testing in diagnosing PD, we analyzed data from 262 PD participants and 50 controls performing several motor tasks wearing a sensor on their lower back containing a triaxial accelerometer and a triaxial gyroscope.
View Article and Find Full Text PDFArticle Synopsis
- Clinical trials are essential for determining the safety and effectiveness of drugs and vaccines, but they typically take over ten years; however, recent global health emergencies like COVID-19 have shown that these trials can be accelerated.
- A study analyzed drugs targeting infectious diseases authorized by the European Medicines Agency from 2012 to 2022, finding a median clinical development time of 7.3 years, but significantly shorter times for COVID-19 (1.3 years) and Ebola (5.5 years).
- Key factors for faster development included the outbreak context, which reduced time by an average of 5.4 years, and the use of accelerated assessment by the EMA, leading to additional time savings.